2020
DOI: 10.1590/1516-4446-2018-0331
|View full text |Cite
|
Sign up to set email alerts
|

Combined influence of illness duration and medication type on visual sensitivity in schizophrenia

Abstract: Objective: Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function. Methods: Data were collected from 50 healthy controls and 50 outpatients wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…The frontal lobes in particular have been shown to be vulnerable to the progressive effects of schizophrenia-related morbidity ( Molina et al, 2004 , Premkumar et al, 2006 ), with regional dysconnectivity ( Woodruff et al, 1997 ) as well as a decline in structural integrity and function as illness persists ( Elsabagh et al, 2009 , Premkumar et al, 2008 ). Consistently, illness duration is a significant predictor of cognitive deficits ( Irani et al, 2011 ), with deterioration in cognitive abilities over the course of illness ( Altamura et al, 2015 , Almeida et al, 2019 , Wood et al, 2002 , Mathes et al, 2005 ). Our findings suggest illness duration-related changes in brain function that may lead to greater variability in patterns of brain activity.…”
Section: Discussionmentioning
confidence: 93%
See 3 more Smart Citations
“…The frontal lobes in particular have been shown to be vulnerable to the progressive effects of schizophrenia-related morbidity ( Molina et al, 2004 , Premkumar et al, 2006 ), with regional dysconnectivity ( Woodruff et al, 1997 ) as well as a decline in structural integrity and function as illness persists ( Elsabagh et al, 2009 , Premkumar et al, 2008 ). Consistently, illness duration is a significant predictor of cognitive deficits ( Irani et al, 2011 ), with deterioration in cognitive abilities over the course of illness ( Altamura et al, 2015 , Almeida et al, 2019 , Wood et al, 2002 , Mathes et al, 2005 ). Our findings suggest illness duration-related changes in brain function that may lead to greater variability in patterns of brain activity.…”
Section: Discussionmentioning
confidence: 93%
“…As such, illness duration is considered an estimate, where the time span from disorder onset to proper diagnosis cannot be accounted for. Additionally, as detailed medical history was not available, conclusions that can be drawn from this study are limited by potential effects of medication ( Almeida et al, 2019 ) or other secondary effects such as sedentary lifestyle, social isolation, etc. that may play an important moderating role.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations